{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T18:28:39Z","timestamp":1781720919445,"version":"3.54.5"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2003,11,1]],"date-time":"2003-11-01T00:00:00Z","timestamp":1067644800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Travel Medicine and Infectious Disease"],"published-print":{"date-parts":[[2003,11]]},"DOI":"10.1016\/j.tmaid.2003.10.001","type":"journal-article","created":{"date-parts":[[2003,12,5]],"date-time":"2003-12-05T11:42:11Z","timestamp":1070624531000},"page":"219-226","source":"Crossref","is-referenced-by-count":23,"title":["Vaccination options for last-minute travellers in need of travel-related prophylaxis against hepatitis A and B and typhoid fever: a practical guide"],"prefix":"10.1016","volume":"1","author":[{"given":"Jane N","family":"Zuckerman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Van Damme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Van Herck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"L\u00f6scher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tmaid.2003.10.001_BIB1","series-title":"International travel and health","year":"2003"},{"issue":"suppl 1","key":"10.1016\/j.tmaid.2003.10.001_BIB2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00063030-200317001-00001","article-title":"Vaccination priorities in travel","volume":"17","author":"Zuckerman","year":"2003","journal-title":"Biodrugs"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB3","series-title":"Travel health knowledge, attitudes and practice among European travelers","author":"Steffen","year":"2003"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2310\/7060.2003.31638","article-title":"Travelers' knowledge, attitudes, and practices on prevention of infectious diseases: results from a pilot study","volume":"10","author":"Van Herck","year":"2003","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB5","series-title":"Travel health knowledge, attitudes and practice among Asian travelers","author":"Nor","year":"2003"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB6","series-title":"Travel health knowledge, attitudes and practice among US International travelers","volume":"1","author":"Connor","year":"2003"},{"issue":"suppl 1","key":"10.1016\/j.tmaid.2003.10.001_BIB7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/00063030-200317001-00003","article-title":"Rapid hepatitis B immunisation for the traveller","volume":"17","author":"Bock","year":"2003","journal-title":"Biodrugs"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB8","series-title":"Rapid seroconversion rates after first dose of an inactivated hepatitis A vaccine (Havrix 1440\u2122): results of a retrospective analysis","volume":"210","author":"Van Damme","year":"2002"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB9","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0924-8579(02)00286-8","article-title":"Vaccination priorities","volume":"21","author":"Steffen","year":"2003","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB10","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1708-8305.1999.tb00841.x","article-title":"Vaccination of travelers against hepatitis A and B","volume":"6","author":"L\u00f6scher","year":"1999","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB11","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1001\/jama.1994.03520110065031","article-title":"Epidemiology and prevention of hepatitis A in travelers","volume":"272","author":"Steffen","year":"1994","journal-title":"JAMA"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.2310\/7060.2000.00054","article-title":"Risks of hepatitis B in travelers as compared to immunization status","volume":"7","author":"Zuckerman","year":"2000","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB13","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/0264-410X(93)90221-I","article-title":"Hepatitis A and hepatitis B: risks compared with other vaccine preventable diseases and immunization recommendations","volume":"11","author":"Steffen","year":"1993","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1708-8305.1998.tb00468.x","article-title":"What type of travelers would benefit from combined vaccination against hepatitis A and B?","volume":"5","author":"Iwarson","year":"1998","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB15","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1136\/bmj.316.7140.1317","article-title":"New combined hepatitis A and B vaccine. Risks of viral hepatitis related to travel","volume":"316","author":"Zuckerman","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB16","doi-asserted-by":"crossref","first-page":"85","DOI":"10.2310\/7060.2000.00027","article-title":"Sources of health advice given to travelers","volume":"7","author":"Leggat","year":"2000","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB17","first-page":"85","article-title":"Vaccinations for international travel","volume":"42","author":"Steffen","year":"1989","journal-title":"World Health Stat Q"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB18","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/0140-6736(93)90814-W","article-title":"Mefloquine compared with other malaria chemoprophylactic regimens in tourists visiting east Africa","volume":"341","author":"Steffen","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/jama.281.9.811","article-title":"Epidemiology, etiology, and impact of traveler's diarrhea in Jamaica","volume":"281","author":"Steffen","year":"1999","journal-title":"JAMA"},{"issue":"suppl 1","key":"10.1016\/j.tmaid.2003.10.001_BIB20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.2165\/00063030-200317001-00005","article-title":"Rapid protection and vaccination against hepatitis A for travellers","volume":"17","author":"Connor","year":"2003","journal-title":"Biodrugs"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB21","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/BF01713047","article-title":"Clinical development of a new inactivated hepatitis A vaccine","volume":"24","author":"Vidor","year":"1996","journal-title":"Infection"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB22","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0264-410X(95)93140-5","article-title":"Good immunogenicity of GBM strain inactivated hepatitis A vaccine in healthy male adults","volume":"13","author":"Garin","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB23","first-page":"15","article-title":"Public health control of hepatitis A: memorandum from a WHO meeting","volume":"73","year":"1995","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB24","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/S0140-6736(03)14418-2","article-title":"Hepatitis A booster vaccination\u2014is there a need?","volume":"362","author":"Van Damme","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB25","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/0264-410X(96)00059-X","article-title":"Interference assessment of yellow fever vaccine with the immune response to a single-dose inactivated hepatitis A vaccine (1440 EL.U.). A controlled study in adults","volume":"14","author":"Gil","year":"1996","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB26","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/j.1708-8305.1998.tb00483.x","article-title":"Concomitant vaccination against hepatitis A and typhoid fever","volume":"5","author":"Van Hoecke","year":"1998","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB27","doi-asserted-by":"crossref","first-page":"74","DOI":"10.2310\/7060.2000.00025","article-title":"Does the concurrent administration of an inactivated hepatitis A vaccine influence the immune response to other travelers vaccines?","volume":"7","author":"Bock","year":"2000","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB28","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/jmv.1094","article-title":"Long-term persistence of antibodies induced by vaccination and safety follow-up, with the first combined vaccine against hepatitis A and B in children and adults","volume":"65","author":"Van Damme","year":"2001","journal-title":"J Med Virol"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB29","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0264-410X(98)00421-6","article-title":"The first combined vaccine against hepatitis A and B: an overview","volume":"17","author":"Thoelen","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB30","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1016\/S0264-410X(01)00240-7","article-title":"A prospective, randomized, comparative US trial of a combination hepatitis A and B vaccine (Twinrix) with corresponding monovalent vaccines (Havrix and Engerix-B) in adults","volume":"19","author":"Joines","year":"2001","journal-title":"Vaccine"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB31","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2310\/7060.2000.00073","article-title":"A single dose, combined vaccine against typhoid fever and hepatitis A: consistency, immunogenicity and reactogenicity","volume":"7","author":"Beran","year":"2000","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB32","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1708-8305.1995.tb00661.x","article-title":"Accelerated schedule for hepatitis B immunization","volume":"2","author":"Bock","year":"1995","journal-title":"J Travel Med"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB33","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/infdis\/172.1.258","article-title":"A 3-week hepatitis B vaccination schedule provides rapid and persistent protective immunity: a multicenter, randomized trial comparing accelerated and classic vaccination schedules","volume":"172","author":"Marchou","year":"1995","journal-title":"J Infect Dis"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB34","first-page":"324","article-title":"Comparison of conventional and accelerated hepatitis B immunisation schedules for homeless drug users","volume":"5","author":"Wright","year":"2002","journal-title":"Commun Dis Public Health"},{"issue":"1","key":"10.1016\/j.tmaid.2003.10.001_BIB35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00063030-200317001-00004","article-title":"Rapid protection against hepatitis A and B using an accelerated vaccination schedule","volume":"17","author":"Nothdurft","year":"2003","journal-title":"Biodrugs"},{"issue":"1","key":"10.1016\/j.tmaid.2003.10.001_BIB36","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2165\/00063030-200317001-00002","article-title":"Immunisation against hepatitis A, hepatitis B and typhoid fever via combined vaccination","volume":"17","author":"Proell","year":"2003","journal-title":"Biodrugs"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB37","series-title":"Immunogenicity and safety of a combined typhoid fever and hepatitis A vaccine: a comparison of a combined vaccine in a dual-chamber syringe versus the monovalent vaccines","author":"Overbosch","year":"2001"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB38","series-title":"Harrison's principles of internal medicine","first-page":"671","article-title":"Salmonellosis","author":"Keusch","year":"1994"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB39","year":"2001","journal-title":"Preventing typhoid fever: a guide for travellers. November 1, 2001. Available from: http:\/\/www.cdc.gov\/travel\/typhoid.htm"},{"key":"10.1016\/j.tmaid.2003.10.001_BIB40","series-title":"International Travel and Health","article-title":"Vaccine preventable diseases and vaccination","year":"2003"}],"container-title":["Travel Medicine and Infectious Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147789390300084X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147789390300084X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,16]],"date-time":"2019-02-16T12:25:05Z","timestamp":1550319905000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147789390300084X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,11]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,11]]}},"alternative-id":["S147789390300084X"],"URL":"https:\/\/doi.org\/10.1016\/j.tmaid.2003.10.001","relation":{},"ISSN":["1477-8939"],"issn-type":[{"value":"1477-8939","type":"print"}],"subject":[],"published":{"date-parts":[[2003,11]]}}}